Received Apr 2, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
Sinus infection one day after dose 1; This non-serious case was reported by a other health professional and described the occurrence of sinus infection in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix .5 ml. On an unknown date, 1 day after receiving Shingrix, the patient experienced sinus infection (Verbatim: Sinus infection one day after dose 1). The outcome of the sinus infection was resolved. It was unknown if the reporter considered the sinus infection to be related to Shingrix. It was unknown if the company considered the sinus infection to be related to Shingrix. Additional Information: GSK Receipt Date: 28-MAR-2026 The reporter mentioned that the patient was not sure if the sinus infection was related to Shingrix. The patient was planning on getting dose 2. The batch number was not provided upon follow- up with the reporter.